Andrea Ganna is an Associate Professor at Institute for Molecular Medicine Finland (FIMM), HiLIFE and a research
associate at Massachusetts General Hospital, Harvard Medical School. Andrea’s research interests lie at the
intersection between epidemiology, genetics, and statistics. He leads a diverse group of 18 researchers including
biologists, mathematicians, and medical doctors. He is co-leading the INTERVENE consortium, which aims to
integrate AI and human genetics tools for disease prevention and diagnosis across biobanks in Europe. He has
been honored with the Leena Peltonen Prize for Excellence in Human Genetics and an ERC Starting Grant. Under
this grant, he launched the FinRegistry project, one of the most comprehensive registry-based health studies in
the world. Within FinRegistry, Andrea’s team, utilizes AI and machine learning to improve early disease detection
and improve public health interventions.